Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
0(0%)
Results Posted
33%(3 trials)

Phase Distribution

Ph phase_1
4
44%
Ph phase_2
4
44%
Ph phase_3
1
11%

Phase Distribution

4

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
4(44.4%)
Phase 2Efficacy & side effects
4(44.4%)
Phase 3Large-scale testing
1(11.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(9)

Detailed Status

Completed9

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (44.4%)
Phase 24 (44.4%)
Phase 31 (11.1%)

Trials by Status

completed9100%

Recent Activity

0 active trials
Showing 5 of 9
completedphase_2

Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive Disorder

NCT05536414
completedphase_3

P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety

NCT06973577
completedphase_1

A Trial to Assess How Centanafadine Interacts With Stimulants in the Body

NCT07314333
completedphase_1

Trial to Demonstrate the Equivalence of Two Different Strengths of Oral Centanafadine Capsules in Healthy Subjects

NCT07486895
completedphase_2

A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating Disorder

NCT05113953
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT05536414Phase 2

Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive Disorder

Completed
NCT06973577Phase 3

P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety

Completed
NCT07314333Phase 1

A Trial to Assess How Centanafadine Interacts With Stimulants in the Body

Completed
NCT07486895Phase 1

Trial to Demonstrate the Equivalence of Two Different Strengths of Oral Centanafadine Capsules in Healthy Subjects

Completed
NCT05113953Phase 2

A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating Disorder

Completed
NCT05066724Phase 2

Efficacy of Centanafadine SR as a Potential Smoking Cessation Treatment

Completed
NCT04786730Phase 1

A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder

Completed
NCT04081363Phase 2

Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Pediatric Participants With Attention-deficit Hyperactivity Disorder (ADHD)

Completed
NCT04398225Phase 1

A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine in Pediatric Subjects With Attention-deficit/Hyperactivity Disorder

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9